MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 09, 2023 for Shree Rasbihari Trading and Investments Pvt Ltd MANGALAM DRUGS & ORGANICS LTD. - 532637 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith copies of newspaper advertisement published in Financial Express (English daily) and Loksatta (Marathi daily), both dated May 31, 2023 in which Audited Financial Results of the Company for the quarter and year ended May 31, 2023 have been published. The aforesaid results have been approved by the Board of Directors in its meeting held on May 30, 2023. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With respect to the captioned subject and mentioned reference, we are pleased to inform that the Board of Directors of the Company, in their meeting held on Tuesday, May 30, 2023 has inter-alia transacted the following business: Appointment Secretarial Auditor of the Company for Financial Year 2022-23. (Brief Profile is attached herewith as Annexure - I) We request you to take the same on your records. MANGALAM DRUGS & ORGANICS LTD. - 532637 - Related Party Transaction For The Period Ended March 31 2023
Related Party transactions for the period ended March 31 2023 MANGALAM DRUGS & ORGANICS LTD. - 532637 - Appointment Of Internal Auditor Of The Company For The Financial Year 2023-24. (Brief Profile Is Attached Herewith As Annexure II)
Appointment of Internal Auditor of the Company for the Financial Year 2023-24. (Brief profile is attached herewith as Annexure II) MANGALAM DRUGS & ORGANICS LTD. - 532637 - FINANCIAL RESULTS FOR THE FINANCIAL YEAR ENDED 31ST MARCH 2023
With respect to the captioned subject and mentioned reference, we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Tuesday, May 30, 2023 has inter-alia transacted the following business: The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2023 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexure I.) MANGALAM DRUGS & ORGANICS LTD. - 532637 - Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday, May 30, 2023,
Dear Sir / Madam, With respect to the captioned subject and mentioned reference, we are pleased to inform that the Board of Directors of the Company, in their meeting held today i.e., Tuesday, May 30, 2023 has inter-alia transacted the following business: The Audited Financial Results (Standalone) for the quarter and Financial Year ended March 31, 2023 pursuant to Regulation 33 of the SEBI LODR Regulations. (A copy of the said results, notes thereto and Auditor's Report is annexed hereto and marked as Annexure I.) Appointment of Internal Auditor of the Company for the Financial Year 2023-24. (Brief profile is attached herewith as Annexure II) Appointment Secretarial Auditor of the Company for Financial Year 2022-23. (Brief Profile is attached herewith as Annexure - III) MANGALAM DRUGS & ORGANICS LTD. - 532637 - Compliances-Reg.24(A)-Annual Secretarial Compliance
In terms of provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, please find enclosed Annual Secretarial Compliance Report for the Financial Year ended March 31, 2023. We request you to take the same on your records.
